Towa Pharmaceutical Co., Ltd.
東和薬品(株)
2026/08/06 Updated
Market Cap:
$1.2B (¥189.8B)
Stock Price:
$24.44 (¥3,855)
Exchange Rate: 1 USD = ¥157.73
Regarding the Financial Disclosure Documents
Earnings overview document including trends in net sales and operating income. First quarter results for the fiscal year ending March 2027 and reference materials are posted.
Key Figures
- Unknown regarding net sales, operating income, and ordinary income—see the PDF body for details
- Filing period: First quarter of the fiscal year ending March 2027
- Reference materials: Includes financial summary and reference materials
AI要約
Section Heading
The key points of the earnings and reference materials are presented, focusing on understanding the company's financial status. May include explanations of trends in sales and profit items and their drivers.
Second Section Heading
An explanation is expected regarding YoY comparisons and the first-half plan, and the impact of major factors (changes in sales volume, trends in cost items).
This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.
Toho Pharmaceutical Co., Ltd.
Company overview · Stock price · Financial data · All IR
